1. Home
  2. JLL vs ALGN Comparison

JLL vs ALGN Comparison

Compare JLL & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JLL
  • ALGN
  • Stock Information
  • Founded
  • JLL 1997
  • ALGN 1997
  • Country
  • JLL United States
  • ALGN United States
  • Employees
  • JLL N/A
  • ALGN N/A
  • Industry
  • JLL Real Estate
  • ALGN Industrial Specialties
  • Sector
  • JLL Finance
  • ALGN Health Care
  • Exchange
  • JLL Nasdaq
  • ALGN Nasdaq
  • Market Cap
  • JLL 12.1B
  • ALGN 12.5B
  • IPO Year
  • JLL 1997
  • ALGN N/A
  • Fundamental
  • Price
  • JLL $257.05
  • ALGN $202.20
  • Analyst Decision
  • JLL Strong Buy
  • ALGN Buy
  • Analyst Count
  • JLL 7
  • ALGN 13
  • Target Price
  • JLL $310.00
  • ALGN $239.33
  • AVG Volume (30 Days)
  • JLL 504.0K
  • ALGN 872.2K
  • Earning Date
  • JLL 08-06-2025
  • ALGN 07-30-2025
  • Dividend Yield
  • JLL N/A
  • ALGN N/A
  • EPS Growth
  • JLL 78.40
  • ALGN N/A
  • EPS
  • JLL 11.07
  • ALGN 5.50
  • Revenue
  • JLL $24,054,800,000.00
  • ALGN $3,980,843,000.00
  • Revenue This Year
  • JLL $10.02
  • ALGN $5.73
  • Revenue Next Year
  • JLL $8.25
  • ALGN $5.58
  • P/E Ratio
  • JLL $23.22
  • ALGN $36.65
  • Revenue Growth
  • JLL 13.63
  • ALGN 1.64
  • 52 Week Low
  • JLL $194.36
  • ALGN $141.74
  • 52 Week High
  • JLL $288.50
  • ALGN $263.24
  • Technical
  • Relative Strength Index (RSI)
  • JLL 61.43
  • ALGN 67.17
  • Support Level
  • JLL $251.91
  • ALGN $192.23
  • Resistance Level
  • JLL $261.32
  • ALGN $205.36
  • Average True Range (ATR)
  • JLL 5.84
  • ALGN 5.62
  • MACD
  • JLL 0.03
  • ALGN 1.37
  • Stochastic Oscillator
  • JLL 79.50
  • ALGN 88.53

About JLL Jones Lang LaSalle Incorporated

Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $74 billion for clients across diverse public and private real estate strategies.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: